Review

Histopathology of Type 1 Diabetes: Old Paradigms and New Insights

Ken T. Coppieters, Matthias G. von Herrath

Manuscript submitted July 18, 2009; resubmitted August 6, 2009; accepted August 6, 2009.

Keywords: type 1 diabetes, beta-cell, cytotoxic T lymphocyte, autoantibody, insulitis, virus, pancreas, inflammation, apoptosis, replication

Abstract

Although our knowledge on the various aspects of diabetes development in the NOD mouse model is substantial and keeps expanding at a dramatic pace, the dataset on histopathologic features of type 1 diabetes (T1D) in patients remains largely stagnant. Early work has established an array of common aspects that have become epitomic in the absence of new patient material. There is a growing consensus that an updated and more detailed view is required that challenges and expands our understanding. Comprehensive initiatives are currently ongoing to address these issues in pre-diabetic, recent onset and longstanding type 1 diabetic individuals, and some of the old data have been recently revisited. In this review article, we wish to provide an overview of where we stand today and how we can correlate the various cross-sectional studies from the past with contemporary models of the disease. We believe an enhanced understanding of the many histopathological particularities in patients as compared to animal models will ultimately lead, not only to more fundamental insights, but also to an improved ability to translate pre-clinical data from bench to bedside.

Fulltext: HTML , PDF (2.9 MB)

This article has been cited by other articles:

	Pathogenic Mechanisms in Type 1 Diabetes: The Islet is Both Target and Driver of Disease Graham KL, Sutherland RM, Mannering SI, Zhao Y, Chee J, Krishnamurthy B, Thomas HE, Lew AM, Kay TW Rev Diabet Stud 2012. 9(4):148-168
	Clinical potential of antigen-specific therapies in type 1 diabetes Coppieters KT, Sehested Hansen B, von Herrath MG Rev Diabet Stud 2012. 9(4):328-337
	Intravital imaging of CTLs killing islet cells in diabetic mice Coppieters K, Amirian N, von Herrath M J Clin Invest 2012. 122(1):119-131
	Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO, von Herrath MG J Exp Med 2012. 209(1):51-60
	Virus infections in type 1 diabetes Coppieters KT, Boettler T, von Herrath M Cold Spring Harb Perspect Med 2012. 2(1):a007682
	Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes Waldron-Lynch F, Herold KC Nat Rev Drug Discov 2011. 10(6):439-452
	A case of type I diabetes mellitus caused by low-dose, long-term natural interferon a therapy for a patient with chronic hepatitis C Hayashi T, Kainuma M, Taniai H, Murata M, Okada K, Sawayama Y, Furusyo N, Hayashi J Acta Hepatologica Japonica 2011. 52(6):335-343
	Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice Coppieters KT, Amirian N, von Herrath MG Clin Exp Immunol 2011. 165(2):155-162
	Type 1 diabetes: etiology, immunology, and therapeutic strategies van Belle TL, Coppieters KT, von Herrath MG Physiol Rev 2011. 91(1):79-118
	Viruses and Cytotoxic T Lymphocytes in Type 1 Diabetes Coppieters KT, von Herrath MG Clin Rev Allergy Immunol 2011. In press
	Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes Johnson MC, Wang B, Tisch R Hum Vaccin 2011. 7(1):27-36
	Protection against or triggering of type 1 diabetes? Different roles for viral infections Boettler T, von Herrath M Expert Rev Clin Immunol 2011. 7(1):45-53
	A novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopy Coppieters K, Martinic MM, Kiosses WB, Amirian N, von Herrath M PLoS One 2010. 5(12):e15732
	Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host Hober D, Sauter P Nat Rev Endocrinol 2010. 6(5):279-289
	The role of the CXCL10/CXCR3 system in type 1 diabetes Shimada A, Oikawa Y, Yamada Y, Okubo Y, Narumi S Rev Diabet Stud 2009. 6(2):81-84
	Breakthrough in diabetes therapy ... Just around the corner? Rudert WA, Trucco M Rev Diabet Stud 2009. 6(2):76-80